These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 25485348

  • 1. First report on long-term clinical results after treatment of coronary bifurcation lesions with the Tryton dedicated bifurcation stent.
    Grundeken MJ, Kraak RP, Baan J, Arkenbout EK, Piek JJ, Vis MM, Henriques JP, Koch KT, Tijssen JG, de Winter RJ, Wykrzykowska JJ.
    Catheter Cardiovasc Interv; 2014 Nov 01; 84(5):759-65. PubMed ID: 25485348
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study.
    Généreux P, Kini A, Lesiak M, Kumsars I, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, Tarantini G, Bettinger N, Minalu Ayele G, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB.
    Catheter Cardiovasc Interv; 2016 Jun 01; 87(7):1231-41. PubMed ID: 26397982
    [Abstract] [Full Text] [Related]

  • 3. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
    Magro M, Wykrzykowska J, Serruys PW, Simsek C, Nauta S, Lesiak M, Stanislawska K, Onuma Y, Regar E, van Domburg RT, Grajek S, Geuns RJ.
    Catheter Cardiovasc Interv; 2011 May 01; 77(6):798-806. PubMed ID: 20824767
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P, Kumsars I, Lesiak M, Kini A, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB.
    J Am Coll Cardiol; 2015 Feb 17; 65(6):533-43. PubMed ID: 25677311
    [Abstract] [Full Text] [Related]

  • 5. Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions.
    Grundeken MJ, Smits M, Harskamp RE, Damman P, Woudstra P, Hoorweg AJ, Baan J, Arkenbout EK, Piek JJ, Vis MM, Henriques JP, Koch KT, Tijssen JG, de Winter RJ, Wykrzykowska JJ.
    Neth Heart J; 2012 Nov 17; 20(11):439-46. PubMed ID: 22763848
    [Abstract] [Full Text] [Related]

  • 6. Gender differences in patients treated with the zotarolimus-eluting stent at a tertiary medical center.
    Shammas NW, Shammas GA, Lemke J, Miller S, Meriner S.
    J Invasive Cardiol; 2012 Jun 17; 24(6):256-60. PubMed ID: 22684377
    [Abstract] [Full Text] [Related]

  • 7. Placement of Tryton Side Branch Stent only; a new treatment strategy for Medina 0,0,1 coronary bifurcation lesions.
    Grundeken MJ, Agostoni P, Lesiak M, Koch KT, Voskuil M, de Winter RJ, Wykrzykowska JJ, Stella PR.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):E395-402. PubMed ID: 23554121
    [Abstract] [Full Text] [Related]

  • 8. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C, Adriaenssens T, Ughi G, Wiyono S, Bennett J, Coosemans M, Ferdinande B, Sinnaeve P, D'hooge J, Desmet W.
    Catheter Cardiovasc Interv; 2013 Feb 01; 81(3):E155-64. PubMed ID: 22745031
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of the Tryton Side Branch Stent™ for the treatment of coronary bifurcation lesions: an update.
    Grundeken MJ, de Winter RJ, Wykrzykowska JJ.
    Expert Rev Med Devices; 2017 Jul 01; 14(7):545-555. PubMed ID: 28581348
    [Abstract] [Full Text] [Related]

  • 10. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies.
    Grundeken MJ, Asgedom S, Damman P, Lesiak M, Norell MS, Garcia E, Bethencourt A, Woudstra P, Koch KT, Vis MM, Henriques JP, Onuma Y, Foley DP, Bartorelli AL, Stella PR, Tijssen JG, de Winter RJ, Wykrzykowska JJ.
    EuroIntervention; 2013 Jun 22; 9(2):195-203. PubMed ID: 23360690
    [Abstract] [Full Text] [Related]

  • 11. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M, Serruys PW, Miquel-Hebert K, Neumann FJ, Piek JJ, Grube E, Haase J, Thuesen L, Hamm C.
    Catheter Cardiovasc Interv; 2010 Jun 01; 75(7):997-1003. PubMed ID: 20517959
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study.
    Tarantini G, La Vecchia L, Galli M, Favero L, D'Amico G, Buja P, Russo F, Cabianca E, Napodano M, Musumeci G, Franceschini E, Grassi G, Pavei A, Bonmassari R, Cernetti C, Spedicato L, Caprioglio F, Reimers B, Isabella G.
    Int J Cardiol; 2013 Oct 15; 168(6):5323-8. PubMed ID: 24007969
    [Abstract] [Full Text] [Related]

  • 13. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).
    Chen SL, Ye F, Zhang JJ, Xu T, Tian NL, Liu ZZ, Lin S, Shan SJ, Ge Z, You W, Liu YQ, Qian XS, Li F, Yang S, Kwan TW, Xu B, Stone GW.
    JACC Cardiovasc Interv; 2015 Apr 20; 8(4):536-46. PubMed ID: 25819187
    [Abstract] [Full Text] [Related]

  • 14. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR, Vaknin-Assa H, Lev E, Teplitsky I, Dvir D, Brosh D, Bental T, Battler A, Kornowski R.
    Catheter Cardiovasc Interv; 2012 Mar 01; 79(4):615-22. PubMed ID: 22162218
    [Abstract] [Full Text] [Related]

  • 15. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study.
    Généreux P, Kumsars I, Schneider JE, Lesiak M, Redfors B, Cornelis K, Selmon MR, Dens J, Hoye A, Metzger DC, Muyldermans L, Slagboom T, Francese DP, Ayele GM, Laak LL, Bartorelli AL, Cutlip DE, Kaplan AV, Leon MB.
    JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1338-46. PubMed ID: 27388820
    [Abstract] [Full Text] [Related]

  • 16. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry.
    Agostoni P, Foley D, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefèvre T, Stella PR.
    EuroIntervention; 2012 Mar 11; 7(11):1293-300. PubMed ID: 22433192
    [Abstract] [Full Text] [Related]

  • 17. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH, Lee JH, Roh JH, Ahn JM, Yoon SH, Park DW, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Seung KB, Shin WY, Lee NH, Lee BK, Lee SG, Nam CW, Yoon J, Yang JY, Hyon MS, Lee K, Jang JS, Kim HS, Park SW, Park SJ.
    JACC Cardiovasc Interv; 2015 Apr 20; 8(4):550-60. PubMed ID: 25907082
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.